395 related articles for article (PubMed ID: 12057712)
1. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
Ovalle F; Azziz R
Fertil Steril; 2002 Jun; 77(6):1095-105. PubMed ID: 12057712
[TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
3. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.
Dunaif A
Am J Med; 1995 Jan; 98(1A):33S-39S. PubMed ID: 7825639
[TBL] [Abstract][Full Text] [Related]
4. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
[TBL] [Abstract][Full Text] [Related]
5. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
Song DK; Hong YS; Sung YA; Lee H
PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
[TBL] [Abstract][Full Text] [Related]
7. [Genetic aspects of polycystic ovary syndrome].
Jakubowski L
Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome and type 2 diabetes mellitus.
De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance in patients with polycystic ovary syndrome.
Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome.
Sir-Petermann T; Angel B; Maliqueo M; Carvajal F; Santos JL; Pérez-Bravo F
Diabetologia; 2002 Jul; 45(7):959-64. PubMed ID: 12136394
[TBL] [Abstract][Full Text] [Related]
11. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome and insulin: our understanding in the past, present and future.
Mayer SB; Evans WS; Nestler JE
Womens Health (Lond); 2015 Mar; 11(2):137-49. PubMed ID: 25776288
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis.
Kaur S; Archer KJ; Devi MG; Kriplani A; Strauss JF; Singh R
J Clin Endocrinol Metab; 2012 Oct; 97(10):E2016-21. PubMed ID: 22904171
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
Dunaif A
Endocr Rev; 1997 Dec; 18(6):774-800. PubMed ID: 9408743
[TBL] [Abstract][Full Text] [Related]
15. Insulin action in the polycystic ovary syndrome.
Dunaif A
Endocrinol Metab Clin North Am; 1999 Jun; 28(2):341-59. PubMed ID: 10352922
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
Paschou SA; Polyzos SA; Anagnostis P; Goulis DG; Kanaka-Gantenbein C; Lambrinoudaki I; Georgopoulos NA; Vryonidou A
Endocrine; 2020 Jan; 67(1):1-8. PubMed ID: 31538291
[TBL] [Abstract][Full Text] [Related]
17. The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes.
Cho LW; Jayagopal V; Kilpatrick ES; Atkin SL
Ann Clin Biochem; 2009 May; 46(Pt 3):218-21. PubMed ID: 19389885
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous adipocytes from obese hyperinsulinemic women with polycystic ovary syndrome exhibit normal insulin sensitivity but reduced maximal insulin responsiveness.
Lystedt E; Westergren H; Brynhildsen J; Lindh-Astrand L; Gustavsson J; Nystrom FH; Hammar M; Strålfors P
Eur J Endocrinol; 2005 Dec; 153(6):831-5. PubMed ID: 16322388
[TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome.
Nandi A; Chen Z; Patel R; Poretsky L
Endocrinol Metab Clin North Am; 2014 Mar; 43(1):123-47. PubMed ID: 24582095
[TBL] [Abstract][Full Text] [Related]
20. Cardiometabolic risks in PCOS: a review of the current state of knowledge.
Kakoly NS; Moran LJ; Teede HJ; Joham AE
Expert Rev Endocrinol Metab; 2019 Jan; 14(1):23-33. PubMed ID: 30556433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
